Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth-Reference-Cited by-同舟云学术

Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth

Published:2017-11-29 Issue:7683 Volume:552 Page:116-120
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Germano Giovanni,Lamba Simona,Rospo Giuseppe,Barault Ludovic,Magrì Alessandro,Maione Federica,Russo Mariangela,Crisafulli Giovanni,Bartolini Alice,Lerda Giulia,Siravegna Giulia,Mussolin Benedetta,Frapolli Roberta,Montone Monica,Morano Federica,de Braud Filippo,Amirouchene-Angelozzi Nabil,Marsoni Silvia,D’Incalci Maurizio,Orlandi Armando,Giraudo Enrico,Sartore-Bianchi Andrea,Siena Salvatore,Pietrantonio Filippo,Di Nicolantonio Federica,Bardelli Alberto

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature24673.pdf

Reference44 articles.

1. Lord, C. J. & Ashworth, A. The DNA damage response and cancer therapy. Nature 481, 287–294 (2012)

2. Vilar, E. & Gruber, S. B. Microsatellite instability in colorectal cancer—the stable evidence. Nat. Rev. Clin. Oncol. 7, 153–162 (2010)

3. Orthwein, A. et al. A mechanism for the suppression of homologous recombination in G1 cells. Nature 528, 422–426 (2015)

4. Rayner, E. et al. A panoply of errors: polymerase proofreading domain mutations in cancer. Nat. Rev. Cancer 16, 71–81 (2016)

5. Ponti, G., Castellsagué, E., Ruini, C., Percesepe, A. & Tomasi, A. Mismatch repair genes founder mutations and cancer susceptibility in Lynch syndrome. Clin. Genet. 87, 507–516 (2015)

Cited by 484 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapeutic strategies for the treatment of colorectal cancer;Principles of Immunotherapy Breast and Gastrointestinal Cancers;2025

2. DNA repair-dependent immunogenic liabilities in colorectal cancer: opportunities from errors;British Journal of Cancer;2024-09-13

3. The Road Ahead in Pancreatic Cancer: Emerging Trends and Therapeutic Prospects;Biomedicines;2024-09-02

4. Challenges and future perspectives for the use of temozolomide in the treatment of SCLC;Cancer Treatment Reviews;2024-09

5. Early-onset cancers: Biological bases and clinical implications;Cell Reports Medicine;2024-09